11 June 2024 

BENGALURU: The Global Antibiotic Research & Development Partnership (GARDP) and Bengaluru-based Bugworks Research Inc are collaborating to co-develop a promising new antibiotic compound — “BWC0977” — with broad-spectrum antibiotic activity against multidrug-resistant bacteria that cause life-threatening infections. As per the agreement, GARDP will provide up to $20 million to Bugworks in technical and financial support for the pharmaceutical and clinical co-development of BWC0977.